Rockefeller Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,547
| Closed | -$205K | – | 1679 |
|
|
2024
Q3 | $205K | Buy |
+4,547
| New | +$205K | ﹤0.01% | 1603 |
|
|
2023
Q3 | – | Sell |
-7,400
| Closed | -$359K | – | 1624 |
|
|
2023
Q2 | $359K | Buy |
+7,400
| New | +$359K | ﹤0.01% | 1463 |
|
|
2023
Q1 | – | Sell |
-2,300
| Closed | -$116K | – | 2758 |
|
|
2022
Q4 | $116K | Buy |
2,300
+373
| +19% | +$18.8K | ﹤0.01% | 1958 |
|
|
2022
Q3 | $96K | Hold |
1,927
| – | – | ﹤0.01% | 2014 |
|
|
2022
Q2 | $94K | Sell |
1,927
-448
| -19% | -$21.9K | ﹤0.01% | 1981 |
|
|
2022
Q1 | $142K | Buy |
2,375
+16
| +0.7% | +$957 | ﹤0.01% | 1832 |
|
|
2021
Q4 | $187K | Hold |
2,359
| – | – | ﹤0.01% | 1667 |
|
|
2021
Q3 | $208K | Sell |
2,359
-41
| -2% | -$3.62K | ﹤0.01% | 1573 |
|
|
2021
Q2 | $238K | Buy |
2,400
+800
| +50% | +$79.3K | ﹤0.01% | 1449 |
|
|
2021
Q1 | $143K | Buy |
1,600
+337
| +27% | +$30.1K | ﹤0.01% | 1453 |
|
|
2020
Q4 | $119K | Buy |
1,263
+1,113
| +742% | +$105K | ﹤0.01% | 1373 |
|
|
2020
Q3 | $10K | Buy |
+150
| New | +$10K | ﹤0.01% | 2009 |
|